1. Home
  2. INDP vs YQ Comparison

INDP vs YQ Comparison

Compare INDP & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • YQ
  • Stock Information
  • Founded
  • INDP 2000
  • YQ 2012
  • Country
  • INDP United States
  • YQ China
  • Employees
  • INDP N/A
  • YQ N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • YQ Other Consumer Services
  • Sector
  • INDP Health Care
  • YQ Real Estate
  • Exchange
  • INDP Nasdaq
  • YQ Nasdaq
  • Market Cap
  • INDP 10.2M
  • YQ 12.5M
  • IPO Year
  • INDP N/A
  • YQ 2020
  • Fundamental
  • Price
  • INDP $0.94
  • YQ $1.61
  • Analyst Decision
  • INDP Strong Buy
  • YQ
  • Analyst Count
  • INDP 2
  • YQ 0
  • Target Price
  • INDP $8.50
  • YQ N/A
  • AVG Volume (30 Days)
  • INDP 25.8K
  • YQ 43.0K
  • Earning Date
  • INDP 11-12-2024
  • YQ 12-11-2024
  • Dividend Yield
  • INDP N/A
  • YQ N/A
  • EPS Growth
  • INDP N/A
  • YQ N/A
  • EPS
  • INDP N/A
  • YQ N/A
  • Revenue
  • INDP N/A
  • YQ $28,507,378.00
  • Revenue This Year
  • INDP N/A
  • YQ N/A
  • Revenue Next Year
  • INDP N/A
  • YQ N/A
  • P/E Ratio
  • INDP N/A
  • YQ N/A
  • Revenue Growth
  • INDP N/A
  • YQ 22.55
  • 52 Week Low
  • INDP $0.84
  • YQ $1.48
  • 52 Week High
  • INDP $3.10
  • YQ $3.55
  • Technical
  • Relative Strength Index (RSI)
  • INDP 40.51
  • YQ 36.08
  • Support Level
  • INDP $0.94
  • YQ $1.54
  • Resistance Level
  • INDP $1.01
  • YQ $1.69
  • Average True Range (ATR)
  • INDP 0.06
  • YQ 0.18
  • MACD
  • INDP 0.00
  • YQ -0.01
  • Stochastic Oscillator
  • INDP 28.24
  • YQ 18.50

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About YQ 17 Education & Technology Group Inc.

17 Education & Technology Group Inc is an education technology company in China. It offers to assist students, teachers, schoolmasters, and educational authorities across China to achieve data-driven teaching, learning, and assessment. Geographically group operates in China.

Share on Social Networks: